Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- ChecktodayChange DetectedThe page displays a new revision tag, Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a small patch to the page rendering or backend that does not affect the study details.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a small patch to the page's metadata. The visible content and study details remain unchanged.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a recent update to the page. This change does not alter the study information displayed.SummaryDifference0.1%

- Check57 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', the recruitment status was updated to 'No longer looking for participants', and a site revision tag 'v3.6.0' indicates a recent update.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page shows a revision label updated from v3.5.4 to v3.5.5, indicating a new iteration of the page's content or layout. No study details or results are changed.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a small update to the page's versioning. There are no visible changes to the study data, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.